Jichun Yang

Jichun Yang

Auto-generated profile, based on publicly available information

Jichun Yang

Department of Laboratory Medicine, Chongqing Center for Clinical Laboratory, Chongqing Academy of Medical Sciences, Chongqing General Hospital, School of Medicine, Chongqing University, Chongqing 401147, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2023 in Biomaterials
Verified
Journal Article
Closed access
JYJichun Yang
Jichun Yang
CZChong Zhang
Chong Zhang
XCXiaohui Chen
Xiaohui Chen
DZDaijun Zhou
Daijun Zhou
ZSZixin Sun
Zixin Sun
YLYang Luo
Yang Luo

20 March 2025 in Interdisciplinary Medicine
Verified
Journal Article
Open access
JYJichun Yang
Jichun Yang
YWYuhan Wang
Yuhan Wang
YFYunqian Fu
Yunqian Fu
SWSitong Wang
Sitong Wang
YLYao Luo
Yao Luo
YLYang Luo
Yang Luo
Plant extracellular vesicles (PEVs) are nanoscale vesicles secreted by plant cells with intact membrane architecture, which encapsulate a diverse array of biomolecules, including lipids, proteins and RNA. They are integral to both intra‐cellular communication within plants and inter‐species signaling. Recently, some PEVs have been regarded as competitive candidates for disease therapy due to their beneficial components and distinctive hollow biomembrane structure. However, the broader applications of PEVs are currently impeded by several challenges of complicated extraction processes, compositional heterogeneity, the lack of reliable biomarkers and unclear therapy mechanisms. A detailed comprehension of their preparation techniques and biological functions is essential for leveraging their potential in clinical medicine. This article first presented a synthesis of the current methodologies for PEV isolation, purification and characterization. Then, it revealed the therapeutic implications of PEVs as medicines in some common diseases based on their bioactive molecules inside, such as cancer, inflammation, and metabolic disorders. We especially explored the emerging role of PEVs with low immunogenicity and the power for biological barriers crossing as drug delivery systems, underscoring their potential for further industry and clinical applications. At last, the bottleneck problems and a vision of PEVs for disease therapy were also presented to evoke more insightful deliberation. This review aims to provide directions for the development of PEV‐derived innovative drugs.

12 June 2024 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
YCYi Chen
Yi Chen
HCHengyi Chen
Hengyi Chen
XCXiaohui Chen
Xiaohui Chen
YZYufang Zhang
Yufang Zhang
WTWei Tu
Wei Tu
YLYang Luo
Yang Luo

17 September 2025 in Light: Science & Applications
Verified
Journal Article
Open access
PDF file
ZLZhonghao Li
Zhonghao Li
ZCZhihan Cai
Zhihan Cai
YWYuhan Wang
Yuhan Wang
YLYuliang Liu
Yuliang Liu
GLGuifeng Li
Guifeng Li
TZTao Zhu
Tao Zhu
The mechanical properties of biological fluids serve as early indicators of disease, offering valuable insights into complex physiological and pathological processes. However, the existing technologies struggle to achieve high-throughput measurement, limiting their widespread applications in disease diagnosis. Here, we propose laser-emission vibrational microscopy of microdroplets for high-throughput measurement of the intrinsic mechanical properties of fluids. The microdroplet array supporting high Q-factor (104) whispering gallery modes (WGM) lasing was massively fabricated on a superhydrophobic surface with inkjet printing. Ultrasound was employed to actuate the mechanical vibrations of the microdroplets, and the vibration amplitude was quantified using time-resolved laser spectra. We found that the stimulus-response of the laser emission is strongly dependent on the liquid viscosity. Fast mapping of the microdroplets’ viscosities was achieved by stage scanning. High-throughput screening of hyperlipidemia disease was also demonstrated by performing over 2000 measurements within 25 min. Thanks to the small volume of the microdroplets, a single drop of blood can support over seven million measurements. The high-throughput ability and small sample consumption make it a promising tool for clinical diagnoses based on mechanical properties.

15 August 2025 in ACS Nano
Verified
Journal Article
Closed access
JYJichun Yang
Jichun Yang
YWYuhan Wang
Yuhan Wang
KWKang Wang
Kang Wang
XCXiaohui Chen
Xiaohui Chen
YLYilin Liu
Yilin Liu
YLYang Luo
Yang Luo

1 February 2026 in Bioactive Materials
Verified
Journal Article
Open access
JYJichun Yang
Jichun Yang
QWQianqian Wu
Qianqian Wu
YFYunqian Fu
Yunqian Fu
XCXiaohui Chen
Xiaohui Chen
HCHengyi Chen
Hengyi Chen
YLYang Luo
Yang Luo
Lung cancer's metastatic propensity and recurrence prevalence necessitate innovative immunotherapy strategies beyond conventional single-mode regulation. We engineered low-capacity turmeric-derived extracellular vesicles (TEVs) that integrated with zeolitic imidazolate framework-8 (ZIF-8) to construct an “all-in-one” nanoagent, addressing both high drug loading nanocarriers production and immunologically cold tumor challenges. The system co-delivered chlorin e6 (Ce6) and PD-L1 siRNA, while exploited TEVs' inherent curcumin for Wnt/β-catenin pathway inhibition. Ce6-mediated photodynamic therapy (PDT) induced immunogenic cell death (ICD), releasing damage associated molecular patterns (DAMPs) to activate antigen-presenting cells (APCs). Compared with control groups, artificial intelligence model confirmed the role of curcumin in enhancing immune infiltration by 6.1-fold. PD-L1 siRNA synergistically downregulates the checkpoint expression with a 66 % reduction in vivo to prevent the immune escape. This coordinated strategy achieved full-cycle immunomodulation: (1) ICD initiated antigens release, (2) Wnt/β-catenin pathway inhibition drived T cell infiltration, and (3) PD-L1 blockade receded the immune escape. In vivo results demonstrated that 64 % primary tumor suppression and 81 % metastasis reduction versus monotherapy groups. The ZIF-8@TEV hybrid platform exhibited 12.8 % payload loading efficiency, surpassing liposomal carriers by 4.7-fold. This study established a scalable nanoengineering approach to transform immunosuppressive tumors into immunotherapy-responsive targets through a full-cycle immune coordination.